glp-1 agonists: A Closer Look at the Dermatological Profile of Agonists GLP-1 Receptor Agonists | New

Results Seven trials (6609 participants) were included

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects

I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)

Although research is currently limited, this is what we know so far.

Best to take before meal